At this point, we tested the MMPs protein expression of transfected RCC cell lines and our data demonstrated that CD82 could down-regulate the expression of MMP2 and MMP9, thus attenuating the migratory ability of RCC cells. The gene discussed is CD82; the disease is renal cell carcinoma.